ARCHIVED - Conference Presentation
The following is a text version of the presentation given at the Conference on Timely Access To Health Care, held February 8-9, 2007 in Toronto, Ontario.
Timely Access to Health Care Priority Area: Cancer: A British Columbia Perspective
Presentation Outline
Cancer as a process
Cancer - Understanding Access, Wait-Times and 'Queues
- Determining and balancing 'need' and capacity'
- Common definitions of wait-times
- Correlating wait-times with appropriate service limitation
- Standards, guidelines, quality and safety of services
- Correlating 'waiting times' with outcomes
Cancer - the BC Cancer Control System
BC - Access, Quality and Timeliness Radiation Services
- Integrated RT system:
- Provincial policy and plans; regional implementation
- All services within one program
- Linked CAIS and RIS (paperless information systems)
- Common IS, standards and portability (networks)
- Continuous monitoring and reporting
- In-house' maintenance
- Provincial determination of 'need' (demand):
- Incidence (projected)
- Utilization rate
- Fractions per course
- Provincial determination of capacity (supply)
- Number of fractions required
- Operating assumptions applied
- Equipment supply (replacement/life-span; new)
Cancer - Screening Mammography Program of BC
- The screening process:
- Identification and invitation to the target group (50-69 years)
- Provision of screening mammograms
- Investigation of abnormalities
- Re-screen reminders at appropriate interval
- Promotion, recruitment and recall - return rate by calendar year.
- Facilitated process to diagnostic investigation (Fast Track)
- Program QA and QC (personnel, process, equipment, reporting)
- Program evaluation and public reporting (Annual Report and web-site)
Cancer - Access, Wait-Times Screening Mammography Program of BC
- Key Issues:
- Setting and achieving accrual targets
- 'hard to reach' populations
- Under 40's, and over 70's
- Capital replacement, expansion, new technology
- HR training and retention
- Key Enabling Factor:
- Fund program by accrual target
Cancer - Cervical Cytology Screening Program of BC
- The screening process:
- Receives smears from BC health professionals according to guidelines and standards
- Provincial program; centralized lab (PHSA)
- Program collaboration with Gynecologic Oncology Tumour Group
- Promotion recruitment and retention - rescreen rates by recommended interval
- Slide interpretation and recommendation to GP
- Program QA and QC
- Program evaluation and public reporting (Annual Report and web-site)
Cancer - Cervical Cytology Screening Program
Cancer - Access, Wait-Times Cervical Cytology Screening Program
- Key issues:
- Slowly declining participation (new screens) - all age groups
- Hard to reach populations
- New technology (HPV testing); HPV vaccination
- Key enabling factors:
- Coordinated, integrated disease management program
- Centralization and coordination through:
- Cervical Cytology Screening Program
- Laboratories
- Gynecologic Oncology Tumour Group
- Colposcopy Program
BC - Access, Quality and Wait-Times Colposcopy
- Provincial program, complimentary to CCSP, aligned to Gynecologic Oncology Tumour Group
- Sessional payment for colposcopies through BCCA (total budget $690K pa)
- 24 funded, hospital-based colposcopy clinics across BC
- 47 registered colposcopists:
- Formal education and training requirements
- Mandatory 12 supervised clinics for new colposcopist
- Annual CME encouraged
- Annual program update attendance mandatory q2yrs
- Defined procedure and care protocols - individual quality reports to colposcopist annually
- Compliance monitoring with colposcopy recommendations
- 75% of all cervical cancer therapeutic procedures performed by GO's
BC Level of Compliance to Colposcopy Recommendations by Age Group
BC - Sustaining and Advancing Provincial Cancer Control
- Provincial population-based, cancer control planning and policy - regional implementation-based on evidence (multiple dimensions)
- Strategic framework for demand and supply projections with prioritization and funding commitment by target/benchmark
- Maintain access, quality and safety standards for all cancer control interventions according to 'targets/benchmarks'
- Investment in, and integration of, science (research) and medicine to foster knowledge translation into best practice.
- System integration through common policies, guidelines and standards for cancer control to overcome outcome disparities
- Introduce new interventions according to evidence for effectiveness, eg colo-rectal cancer screening and approved funding
- Funding according to performance and accountability for cancer control process and outcomes
Page details
- Date modified: